We found 8 drugmaker programs for Duchenne Muscular Dystrophy medicines and 6 charity funds (3 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Duchenne Muscular Dystrophy depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Medical and medication costs.
Covers: Insurance premiums and copays.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Medical equipment (wheelchairs, lifts, canes and other DME). Up to $1,000 a year.
Covers: Copays for FDA-approved medications (plus travel for some funds).
Covers: Out-of-pocket costs for approved medications. Up to $15,400 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
For patients with commercial insurance, Catalyst Pathways lowers out-of-pocket costs to $0 per month.
Free 'Bridge' medicine for new DMD patients enrolled in Catalyst Pathways and prescribed AGAMREE, to cover the gap while insurance coverage is investigated and confirmed. Some restrictions apply.
The Patient Assistance Program provides free medicine to qualifying patients without insurance or whose coverage was denied, for as long as it is needed. Qualification criteria are not published on the page.
Catalyst Pathways care coordinators help with enrollment and financial support questions. Call 1-833-4-CATALYST (1-833-422-8259), Monday to Friday, 7 AM to 7 PM CT. Catalyst Pathways can also refer you to nonprofit foundations that may help with out-of-pocket costs.
In the US, AGAMREE is marketed by Catalyst Pharmaceuticals, which runs Catalyst Pathways. Enroll by completing the enrollment form with your healthcare provider or by calling 1-833-4-CATALYST.
A dedicated SareptAssist Case Manager helps with insurance approvals and coordinating AMONDYS 45 delivery.
Co-pay Assistance Program may help commercially insured patients with co-pays, co-insurance and deductibles. Not for government insurance like Medicare.
Case Managers can share information on a Sarepta Patient Assistance Program. Eligibility is not described on the official pages.
Call 1-888-SAREPTA (Mon-Fri 8:30am-6:30pm ET). Copay terms are on Sarepta's corporate SareptAssist page, which covers 'a Sarepta product'. Who qualifies for the Patient Assistance Program is not stated on official pages; ask the Case Manager.
Case managers help with benefits verification, prior authorizations and appeals, home delivery, pharmacist guidance, and in-home lab monitoring.
Commercially insured patients whose plan covers DUVYZAT may pay as little as $0 per month; annual maximum applies. Government-insured patients are not eligible.
Free DUVYZAT for eligible patients who have no insurance or whose insurance does not cover it.
Temporary supply programs provide medicine while waiting for insurance approval or other processes.
Eligibility is reviewed case by case. Case managers available Mon-Fri 8 AM-8 PM ET.
SareptAssist team helps with treatment logistics and questions before, during and after the one-time ELEVIDYS infusion.
Co-pay Assistance Program may help commercially insured patients with co-pays, co-insurance and deductibles. Not for government insurance like Medicare.
Call 1-888-SAREPTA (Mon-Fri 8:30am-6:30pm ET); only for US patients prescribed ELEVIDYS. Copay terms come from Sarepta's corporate SareptAssist page ('a Sarepta product'). The ELEVIDYS page does not describe a free-drug program. Patient Education Liaisons: 1-888-848-6374.
A dedicated PTC Cares Case Manager verifies insurance, explains benefits and costs, and coordinates with the specialty pharmacy.
Copay Assistance Program helps qualified families with commercial insurance cover out-of-pocket costs; not valid with Medicare or Medicaid.
Bridge Program may give patients already on a PTC medication a temporary free supply while insurance coverage is verified.
PTC Cares may also refer families to independent charitable foundations. A free-drug program for uninsured patients is not described on PTC's pages. Generic deflazacort is also available; these programs are for PTC's EMFLAZA.
A dedicated SareptAssist Case Manager helps with insurance approvals and coordinating EXONDYS 51 delivery.
Co-pay Assistance Program may help commercially insured patients with co-pays, co-insurance and deductibles. Not for government insurance like Medicare.
Case Managers can share information on a Sarepta Patient Assistance Program. Eligibility is not described on the official pages.
Call 1-888-SAREPTA (Mon-Fri 8:30am-6:30pm ET). Copay terms are on Sarepta's corporate SareptAssist page, which covers 'a Sarepta product'. Who qualifies for the Patient Assistance Program is not stated on official pages; ask the Case Manager.
Commercially insured patients receiving Viltepso are automatically enrolled in the NS Support Co-pay Assistance Program, which helps eligible patients with deductible, co-pay and coinsurance costs for Viltepso, with re-enrollment each calendar year while they stay eligible. Restrictions apply; call NS Support for full eligibility terms.
Financial Assistance Program: eligible uninsured patients may get Viltepso at no charge for up to one year. Does not cover infusion costs.
A Patient Engagement Lead and Director of Patient Access help with insurance approvals, reauthorizations, understanding out-of-pocket costs and choosing an infusion provider.
NS Support lists a Bridge Program and a Quick Start Program; details and eligibility are not published. Call NS Support to ask.
Government-insured patients can't use the co-pay program. Hours Mon-Fri 8 AM-8 PM ET.
A dedicated SareptAssist Case Manager helps with insurance approvals and coordinating VYONDYS 53 delivery.
Co-pay Assistance Program may help commercially insured patients with co-pays, co-insurance and deductibles. Not for government insurance like Medicare.
Case Managers can share information on a Sarepta Patient Assistance Program. Eligibility is not described on the official pages.
Call 1-888-SAREPTA (Mon-Fri 8:30am-6:30pm ET). Copay terms are on Sarepta's corporate SareptAssist page, which covers 'a Sarepta product'. Who qualifies for the Patient Assistance Program is not stated on official pages; ask the Case Manager.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 8 drugmaker programs for Duchenne Muscular Dystrophy medicines and 6 charity funds, 3 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Duchenne Muscular Dystrophy, 0 charity funds on this page accept Medicare, and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, NORD RareCare's Duchenne Muscular Dystrophy Medical Assistance fund, NORD RareCare's Duchenne Muscular Dystrophy Premium Copay Assistance fund, The Assistance Fund's Duchenne Muscular Dystrophy fund were open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Duchenne Muscular Dystrophy medicines, 3 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (NORD RareCare, The Assistance Fund, Muscular Dystrophy Association, Good Days, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
